Literature DB >> 1180962

Evidence for the formation of an ester between thrombin and heparin cofactor.

W G Owen.   

Abstract

Heparin cofactor, a thrombin inhibitor, is purified from human plasma by affinity chromatography on heparin-agarose. The nature of the binding between thrombin and the inhibitor is studied by treatment of the complex with 6 M guanidinium chloride, hydroxylamine, and dilute alkali. The complex is not dissociated during gel chromatography in 6 M guanidinium chloride. This result supports an earlier proposal that formation of the complex includes the formation of a covalend bond. Treatment of dodecylsulfate-denatured complex with hydroxylamine results in dissociation of the complex to yield free thrombin and heparin cofactor. The complex is also dissociated in dilute NaOH (pH 12) solutions. These results indicate that the covalent bond between thrombin and the inhibitor is a carboxylic ester.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1180962     DOI: 10.1016/0005-2795(75)90103-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Acute dialysis: PMN-elastase as a new parameter for controlling individual anticoagulation with low molecular weight heparin (Fragmin).

Authors:  H Swars; G Hafner; L S Weilemann; W Ehrenthal; H Schinzel; W Prellwitz; J Meyer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

Authors:  T L Lindahl; P I Ohlsson; B Wiman
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

3.  Inhibition of activated protein C by platelets.

Authors:  S M Jane; C A Mitchell; L Hau; H H Salem
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Cleavage of protein S by a platelet membrane protease.

Authors:  C A Mitchell; H H Salem
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 6.  Revisiting the Pharmacology of Unfractionated Heparin.

Authors:  Abdallah Derbalah; Stephen Duffull; Fiona Newall; Katie Moynihan; Hesham Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

7.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

8.  Cloning and expression of the cDNA for human antithrombin III.

Authors:  S C Bock; K L Wion; G A Vehar; R M Lawn
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

9.  Detection of a new heparin-dependent inhibitor of thrombin in human plasma.

Authors:  D M Tollefsen; M K Blank
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

10.  Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig.

Authors:  P Zoldhelyi; J H Chesebro; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.